Sichuan Huiyu Pharmaceutical

CompanyChina

Sichuan Huiyu Pharmaceutical develops one asset, approved (Ferric Derisomaltose in Anemia, Iron-Deficiency). Mostly other; based in China.

1
Asset
Furthest stage: Approved; 5
Trials: 5
Signals

Pipeline

1

Ferric Derisomaltose
Replenishes iron stores to correct iron deficiency and support oxygen transport and cellular energy metabolism.
Approved, Other, Anemia, Iron-Deficiency, iron deficiency (Phase 3)

Full company profiles: pipeline, trials, funding and people.

In the full profile

Evidence behind the mechanisms1
Trials5
Signals12
Similar companies6